Browse Case Series research papers with clear, practical takeaways for your clinical practice.
Case series describing four patients with cutaneous leishmaniasis, detailing clinical features, histopathology, immunohistochemistry, and outcomes.
Study focusWhen using tomotherapy with paclitaxel for cutaneous angiosarcoma, clinicians can counsel that this series observed a 2-year overall survival of 70%...
Clinical insightXP-A due to c.389G>A (p.R130K) can present with mild cutaneous disease yet later neurologic decline; functional testing can reveal marked NER defects...
Clinical insightA proof-of-concept biological and clinical study examined ustekinumab for bullous pemphigoid.
Study focusA case series evaluated dupilumab as a steroid-sparing treatment for managing cutaneous toxicities related to antibody-drug conjugates.
Study focusA case series of 72 patients with melanoma and an unidentifiable sentinel lymph node, evaluating survival prognostic factors.
Study focusIn older patients with keratoacanthoma-like atypical squamous proliferations of the lower legs, intralesional triamcinolone achieved clinical success...
Clinical insightXA appears to boost visible‑light blocking in ZnO mineral sunscreens and showed no irritation/sensitization in a 100‑subject RIPT, with no...
Clinical insightIn this series, melanoma in Black patients most often arose on acral sites, and advanced acral, mucosal/ocular, and unknown‑primary cases had poor...
Clinical insightA recess-free, skin-responsive device enabled no-shave long-hair FUE with low GTR/SBR and faster harvesting; plan torque and movement by SFS class...
Clinical insightDupilumab can trigger a benign, reversible lymphoid reaction that mimics CTCL in adults with atopic dermatitis; recognizing its distinctive...
Clinical insightSingle-arm study (Nov 2017–Apr 2023) of patients with diabetic ulcers treated weekly using a two-step Er:YAG laser protocol (ablation debridement...
Study focusBe alert to SJS/TEN as a potential post-COVID infection or post-vaccination event; take a recent COVID infection and vaccination history when...
Clinical insightIn patients of African descent undergoing FUE, a skin‑responsive device achieved low mean transection rates (<10%, typically 3%–6%). When planning...
Clinical insightMost cutaneous reactions after CoronaVac or ZF2001 are mild, start within 3 days, and many resolve within 7–14 days with conventional therapy;...
Clinical insightIn selected adult burn patients with severe ARDS who cannot be proned or fail standard measures, ECMO support was feasible, with 66.7% survival to...
Clinical insightYou're all caught up!
You've explored 16 papers
Check back later for more research